Bobinas P4G
  • Login

  • Public

    • Public
    • Groups
    • Popular
    • People

Notices by Eric Topol (erictopol@mstdn.social)

  1. Eric Topol (erictopol@mstdn.social)'s status on Friday, 18-Aug-2023 22:19:02 UTC Eric Topol Eric Topol

    Just published
    When a nasal vaccine provides superior immune response compared with a shot (2 doses of each). Results from a randomized clinical trial, including vs Omicron, and with less local and systemic adverse effects
    https://nature.com/articles/s41541-023-00717-8

    In conversation about a year ago from mstdn.social permalink

    Attachments


    1. https://media.mstdn.social/media_attachments/files/110/912/163/729/947/135/original/ab1e4d20b974c6f3.png
    2. Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®) - npj Vaccines
      from Vadrevu, Krishna Mohan
      npj Vaccines - Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®)

User actions

    Eric Topol

    Eric Topol

    physician-scientist, author, editor

    Tags
    • (None)
    ActivityPub
    Remote Profile

    Following 0

      Followers 0

        Groups 0

          Statistics

          User ID
          48942
          Member since
          18 Aug 2023
          Notices
          1
          Daily average
          0

          Feeds

          • Atom
          • Help
          • About
          • FAQ
          • Privacy
          • Source
          • Version
          • Contact

          Bobinas P4G is a social network. It runs on GNU social, version 2.0.1-beta0, available under the GNU Affero General Public License.

          Creative Commons Attribution 3.0 All Bobinas P4G content and data are available under the Creative Commons Attribution 3.0 license.